93 related articles for article (PubMed ID: 54235)
1. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.
Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
Clin Exp Immunol; 1975 Apr; 20(1):41-54. PubMed ID: 54235
[TBL] [Abstract][Full Text] [Related]
2. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance.
Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
Clin Exp Immunol; 1975 Apr; 20(1):29-40. PubMed ID: 173486
[TBL] [Abstract][Full Text] [Related]
3. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
Chang SG; Lee SJ; Huh JS; Lee JH
Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
5. Change in the proportion of T and B lymphocytes in human malignant neoplasia in relation to the clinical stage.
Babusíková O; L' Novotná ; Korec S; Schneková K; Turková D; Havránková M; Plentová K
Neoplasma; 1975; 22(4):413-21. PubMed ID: 1081657
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
7. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
8. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of the effect of BCG vaccine treatment in bladder tumour patients.
Kulcsár G; Nász I; Tenke P; Csata S
Acta Microbiol Hung; 1993; 40(2):151-7. PubMed ID: 8184669
[TBL] [Abstract][Full Text] [Related]
10. The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions.
Galili U; Schlesinger M
J Immunol; 1976 Sep; 117(3):730-5. PubMed ID: 134120
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
Jakasa D
Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
[No Abstract] [Full Text] [Related]
12. Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection.
Niitsuma M; Golub SH; Edelstein R; Holmes EC
J Natl Cancer Inst; 1981 Nov; 67(5):997-1003. PubMed ID: 6457925
[TBL] [Abstract][Full Text] [Related]
13. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
14. T & B lymphocytes in the spectrum of leprosy.
Chogle JB; Khanolkar SR; Antia NH
Lepr India; 1977 Jan; 49(1):36-43. PubMed ID: 302371
[TBL] [Abstract][Full Text] [Related]
15. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.
Brochier J; Abou-Hamed YA; Gueho JP; Revillard JP
Immunology; 1976 Nov; 31(5):749-58. PubMed ID: 1086826
[TBL] [Abstract][Full Text] [Related]
16. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
17. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
Chisari FV; Routenberg JA; Edgington TS
J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
[TBL] [Abstract][Full Text] [Related]
18. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus.
Miller AB; Taylor HE; Baker MA; Dodds DJ; Falk R; Frappier A; Hill DP; Jindani A; Landi S; Macdonald AS; Thomas JW; Wall C
Can Med Assoc J; 1979 Jul; 121(1):45-54. PubMed ID: 466592
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
Moertel CG; Ritts RE; Schutt AJ; Hahn RG
Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
